Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (191-200 of 290) with videos related to

Pageof 29
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbationMichael M Tunney, Gisli G Einarsson, Lan Wei, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator AntibioticsMiquel B Ekkelenkamp, Rafael Cantón, María Díez-Aguilar, et al.
Annals of the American Thoracic Society|August 30, 2014
Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiJames F Chmiel, Timothy R Aksamit, Sanjay H Chotirmall, et al.
Annals of the American Thoracic Society|August 8, 2014
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsJames F Chmiel, Timothy R Aksamit, Sanjay H Chotirmall, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2009
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF)Akihiro Tazumi, Yasunori Maeda, Colin E Goldsmith, et al.
The Lancet. Respiratory Medicine|May 21, 2017
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trialDaniel F McAuley, Lj Mark Cross, Umar Hamid, et al.
Respirology (Carlton, Vic.)|August 1, 2019
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasisKatherine O'Neill, Gisli G Einarsson, Stephen Rowan, et al.
Plos One|October 27, 2011
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivoAaron Scott, Sinéad Weldon, Paul J Buchanan, et al.
Journal of Medical Microbiology|August 25, 2022
Whole-genome analysis of <i>Haemophilus influenzae</i> strains isolated from persons with cystic fibrosisAd C Fluit, Jumamurat R Bayjanov, Barry J Benaissa-Trouw, et al.
Mediators of Inflammation|April 8, 2021
Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult <i>β</i>ENaC-Tg MiceRyan Brown, Donna M Small, Declan F Doherty, et al.
Pageof 29

Showing results (191-200 of 290) with videos related to

Sort By:
Pageof 29
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbationMichael M Tunney, Gisli G Einarsson, Lan Wei, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator AntibioticsMiquel B Ekkelenkamp, Rafael Cantón, María Díez-Aguilar, et al.
Annals of the American Thoracic Society|August 30, 2014
Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiJames F Chmiel, Timothy R Aksamit, Sanjay H Chotirmall, et al.
Annals of the American Thoracic Society|August 8, 2014
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsJames F Chmiel, Timothy R Aksamit, Sanjay H Chotirmall, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2009
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF)Akihiro Tazumi, Yasunori Maeda, Colin E Goldsmith, et al.
The Lancet. Respiratory Medicine|May 21, 2017
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trialDaniel F McAuley, Lj Mark Cross, Umar Hamid, et al.
Respirology (Carlton, Vic.)|August 1, 2019
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasisKatherine O'Neill, Gisli G Einarsson, Stephen Rowan, et al.
Plos One|October 27, 2011
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivoAaron Scott, Sinéad Weldon, Paul J Buchanan, et al.
Journal of Medical Microbiology|August 25, 2022
Whole-genome analysis of <i>Haemophilus influenzae</i> strains isolated from persons with cystic fibrosisAd C Fluit, Jumamurat R Bayjanov, Barry J Benaissa-Trouw, et al.
Mediators of Inflammation|April 8, 2021
Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult <i>β</i>ENaC-Tg MiceRyan Brown, Donna M Small, Declan F Doherty, et al.
Pageof 29